Uroplasty (NSDQ:UPI) notched a reimbursement win with Independence Blue Cross now covering the Urgent PC device.

The Urgent PC device uses percutaneous tibial nerve stimulation to treat overactive bladder, using an external electrode to stimulate the sacral nerve plexus and alleviate OB symptoms such as urinary urgency, urinary frequency and urge incontinence.

Independence Blue Cross is the largest insurance provider in South East Pennsylvania, providing coverage to 2.2 million people. The reimbursement provides for treatments for up to 2 years, according to a press release.

“This positive coverage decision is another example of the success we are achieving in working directly with payers to demonstrate the cost effectiveness and the clinical benefits of Urgent PC in treating patients with [overactive bladder]," healthcare policy and reimbursement VP Nancy Kolb said in prepared remarks. "We now have approximately 110 million lives covered by private payers and 40 million Medicare beneficiaries with access to Urgent PC therapy following this decision by IBC."

This is more good news for Minnetonka, Minn.-based Uroplasty, which also secured reimbursement coverage from health insurance giants Health Care Service Corp. and Humana for the Urgent PC. Humana is the 6th-largest private U.S. health insurer, with nearly 9 million people covered.